Profile
Full Name
MoonLake ImmunotherapeuticsTicker
NASDAQ: MLTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
SwitzerlandIPO
October 20, 2020Indexes
Not includedWebsite
https://www.moonlaketx.comEmployees
100Key Details
Price
$54.30(+0.18%)
Market cap
$3.45B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$0.00(0.00% YoY)
Annual EPS
-$1.89(-158.90% YoY)
Next earnings date
Nov 6, 2025Next ex-dividend date
N/ANext split date
N/AQuick Search
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Analyst ratings
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
MoonLake Immunotherapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Aug 6, 25 Goldman Sachs
BuyJun 3, 25 RBC Capital
OutperformMay 19, 25 Wolfe Research
OutperformMay 13, 25 Needham
BuyApr 30, 25 Needham
BuyMar 18, 25 RBC Capital
OutperformFeb 27, 25 Needham
BuyFeb 27, 25 HC Wainwright & Co.
BuyFeb 27, 25 Goldman Sachs
BuyJan 17, 25 Goldman Sachs
BuyInstitutional Ownership
- What is the ticker symbol for MoonLake Immunotherapeutics?
- Does MoonLake Immunotherapeutics pay dividends?
- What sector is MoonLake Immunotherapeutics in?
- What industry is MoonLake Immunotherapeutics in?
- What country is MoonLake Immunotherapeutics based in?
- When did MoonLake Immunotherapeutics go public?
- Is MoonLake Immunotherapeutics in the S&P 500?
- Is MoonLake Immunotherapeutics in the NASDAQ 100?
- Is MoonLake Immunotherapeutics in the Dow Jones?
- When was MoonLake Immunotherapeutics's last earnings report?
- When does MoonLake Immunotherapeutics report earnings?
What is the ticker symbol for MoonLake Immunotherapeutics?
The ticker symbol for MoonLake Immunotherapeutics is NASDAQ:MLTX
Does MoonLake Immunotherapeutics pay dividends?
No, MoonLake Immunotherapeutics does not pay dividends
What sector is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is in the Healthcare sector
What industry is MoonLake Immunotherapeutics in?
MoonLake Immunotherapeutics is in the Biotechnology industry
What country is MoonLake Immunotherapeutics based in?
MoonLake Immunotherapeutics is headquartered in Switzerland
When did MoonLake Immunotherapeutics go public?
MoonLake Immunotherapeutics's initial public offering (IPO) was on October 20, 2020
Is MoonLake Immunotherapeutics in the S&P 500?
No, MoonLake Immunotherapeutics is not included in the S&P 500 index
Is MoonLake Immunotherapeutics in the NASDAQ 100?
No, MoonLake Immunotherapeutics is not included in the NASDAQ 100 index
Is MoonLake Immunotherapeutics in the Dow Jones?
No, MoonLake Immunotherapeutics is not included in the Dow Jones index
When was MoonLake Immunotherapeutics's last earnings report?
MoonLake Immunotherapeutics's most recent earnings report was on May 7, 2025
When does MoonLake Immunotherapeutics report earnings?
The next expected earnings date for MoonLake Immunotherapeutics is November 6, 2025